Navigation Links
Cadence Fitness & Health Center Certified as Medical Fitness Facility
Date:1/15/2014

GENEVA, Ill., Jan. 15, 2014 /PRNewswire-USNewswire/ -- The Cadence Fitness & Health Center has been certified as a Medical Fitness Center by the Medical Fitness Association, a non-profit organization assisting medically integrated health and fitness centers to achieve their full potential. The Cadence Fitness & Health Center is the only certified fitness center in the western suburbs and second in the Chicagoland area.

"The certification means the Cadence Fitness & Health Center meets guidelines set by the Medical Fitness Association to ensure that our programs and services deliver medically integrated outcomes to its members," said Brian Babka, M.D., Cadence Physician Group Sports Medicine. "We are proud to offer a variety of programs with an educated approach to help improve the fitness, health and well-being of the communities we serve."

Located in Geneva on the Delnor Campus, the Cadence Fitness & Health Center is a 60,000 square foot, state-of-the-art facility that offers programs overseen by teams of professionally trained and certified health promotion specialists.  The programs offered at the Center include:

  • Cardiac Fitness for cardiac rehab patients;
  • Diabetes Exercise Care Program;
  • Survivor Care for cancer patients;
  • Aftercare for people who have completed physical therapy, but still want a supervised exercise program;
  • Right Weigh for people who are interested in getting their weight under control.

"In addition to personal trainers, many of our members work with dietitians and life coaches and receive pre- and post-program health assessments that are used to set and measure fitness goals," said Babka.

The Medical Fitness Association was founded in 1991.  There are 26 MFA-certified centers in the United States. 

About Cadence Health '/>"/>

SOURCE Cadence Health
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
3. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
6. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
8. Cadence to Open Finished Medical Device Facility
9. Cadence Pharmaceuticals to Host Analyst and Investor Day
10. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
11. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... to 2020 - Broadened Diagnostic Criteria ... Market Growth despite Patent Expirations ... ADHD Therapeutics to 2020 - ...
(Date:8/28/2014)... 28, 2014 Amgen (NASDAQ: AMGN ... Application (BLA) to the U.S. Food and Drug Administration ... high cholesterol. Evolocumab is an investigational fully human monoclonal ... a protein that reduces the liver,s ability to remove ... blood. 1 ­ The ...
(Date:8/28/2014)... , Aug. 28, 2014  Rx Safes, Inc., ... announced that it is waging a new war on ... national media campaign. More than 2,500 children ... time and these drugs are easily accessed from unsecured medicine ... drug dealers on the streets, Rx Safes will address ...
Breaking Medicine Technology:ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9Rx Safes, Inc. Announces New War On Drugs 2
... , SAN DIEGO, Sept. 9 Anadys Pharmaceuticals, Inc. ... in a Phase II trial of ANA598 in patients chronically infected ... over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, ... non-nucleoside polymerase inhibitor. , , "ANA598 has demonstrated ...
... , , HERNDON, Va., Sept. 8 ... that it will initiate a global, Phase 3, multi-center pivotal trial ... proprietary BHR-100 intravenous progesterone infusion product as a neuroprotective agent for ... , BHR will enroll approximately 1,200 patients with ...
Cached Medicine Technology:Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 2Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 3Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 4Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 5BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 2
(Date:8/28/2014)... 28, 2014 ABC television stars will ... MDA Show of Strength Telethon airing Sunday, Aug. 31, ... help raise funds and awareness to help save and ... muscle disease. , Viewers tuning into the 2014 telethon ... appeals and introductions from some of the network’s leading ...
(Date:8/28/2014)... 28, 2014 Biotronic, a Great Point ... neurophysiology monitoring ("IONM") company, today announced the promotion of ... Chief Executive Officer effective immediately. Mr. Gecsey joined Biotronic ... CFO in 2013 and has been an integral part ... efforts and achievements since joining the company in 2010 ...
(Date:8/28/2014)... 2014 Allegheny Health Network ... regional partnership designed to advance sports nutrition education, ... young athletes, scholastic athletes and their families across ... & Mind Initiative will offer a comprehensive and ... and mental dynamics involved in pursuing athletic excellence,” ...
(Date:8/28/2014)... 28, 2014 Valero Renewable Fuels Company, ... (NYSE: VLO), and the Ports of Indiana hosted Lt. ... today at a Port Appreciation and Welcome Celebration commemorating ... plant. , “The opening of Valero’s ethanol facility at ... economic development win for the State of Indiana,” Ellspermann ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Gurnick Academy ... MRI Technology program is re-accredited for the 5 years ... Resonance Imaging Technologists (ARMRIT). , “We are very ... constantly improving our program to make sure we provide ... lot of interest in MRI field nowadays and I ...
Breaking Medicine News(10 mins):Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4Health News:Biotronic NeuroNetwork Announces the Promotion of Bill Gecsey to CEO 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4Health News:Valero, Ports of Indiana Celebrate Restart of Ethanol Plant 2Health News:Valero, Ports of Indiana Celebrate Restart of Ethanol Plant 3Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2
... a blood vessel medication, improved distances 50% ... prescription drug naftidrofuryl eases leg cramps caused by ... farther, according to Belgian researchers. , They reviewed ... condition called intermittent claudication. Patients who took the ...
... Brain function and health will be the focus of the ... in San Francisco. Part of a highly recognized series, ... with the booming aging industry; factors that predict future cognitive ... participate in them. , WHO: , The program is sponsored ...
... On Sunday, June 29,2008, West Coast Bank will sponsor ... Run, Portland,s most unique 8k personal,challenge run., Race ... the,Burnside Bridge by 9:00 a.m. when the bridge rises. ... the Oregon Zoo and winds through the,paved roads of ...
... are estimated to be affected by the devastation caused ... by researchers from the Johns Hopkins Bloomberg School of ... Systems (GIS), the researchers calculated the likely distribution of ... developed maps of the regions at greatest risk from ...
... and Vancouver Coastal Health Research Institute have discovered how ... body and are working toward a treatment to block ... discovery, published today in the journal Cell Host and ... and its newly discovered counterpart protein in the human ...
... broader public action to curb effects , , WEDNESDAY, May 14 ... particulate matter air pollution can increase blood pressure and harm ... , The findings may explain why air pollution can trigger ... failure and stroke, the researchers said. , Particulate matter (PM) ...
Cached Medicine News:Health News:Common Drug Eases Leg Pain From Walking 2Health News:Estimated 3.2 million Burmese potentially affected by cyclone 2Health News:Vancouver researchers discover missing link between TB bacteria and humans 2Health News:Pollution Particles Impair Blood Vessel Function 2
96 channel Parallel dispenser using Positive Air Displacement Technology...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat...
The WP1000S is a shortened base version of the WellPro that is shortened 5 inches to facilitate fitting into smaller biohazard hoods....
... The Labcyte Echo 550 compound ... droplets down to 5 nL using ... on focused acoustic energy. Monitoring of ... fluids enables the Echo 550 to ...
Medicine Products: